Company profile for Que Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

QUE Oncology is a clinical-stage company developing Q-122, a non-hormonal treatment for moderate to severe vasomotor symptoms (hot flashes, night sweats) in postmenopausal women and cancer patients on hormone therapy. Formed in 2013 via a joint venture between Emory University and UniQuest (University of Queensland), QUE is backed by venture firms including MRCF and Uniseed. The company recently completed a randomized, double-...
QUE Oncology is a clinical-stage company developing Q-122, a non-hormonal treatment for moderate to severe vasomotor symptoms (hot flashes, night sweats) in postmenopausal women and cancer patients on hormone therapy. Formed in 2013 via a joint venture between Emory University and UniQuest (University of Queensland), QUE is backed by venture firms including MRCF and Uniseed. The company recently completed a randomized, double-blind, placebo-controlled Phase 2 trial across Australia, New Zealand, and the U.S., which met its primary efficacy endpoint and showed a well-tolerated safety profile.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2870 Peachtree Road, Suite 466, Atlanta, GA 30305
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty